Having established a role for Mcl-1 in the resistance of our GBM cell lines to chemotherapy-induced apoptosis, we investigated if R-roscovitine, given its capacity to decrease Mcl-1, and TRAIL could synergise to induce apoptosis in the treatment-resistant MZ-294 cell line. This evidence concerns the gene MCL1 and glioblastoma.